Skip to main content
. 2022 Jun 29;13:3731. doi: 10.1038/s41467-022-31500-3

Fig. 6. Evaluation of the biodistribution and targeting efficacy of Ts-TPGS/Cap in vivo.

Fig. 6

Fluorescence images of major organs collected from KPN- and TRKP-infected mice with pneumonia (A) at 5 h (B) and 24 h postinjection of TPGS/Cap and Ts-TPGS/Cap nanorods. Semiquantitative analysis of the fluorescence intensity in major organs displayed in (C) Fig. 6A and (D) Fig. 6B (n = 3 mice). Ts-TPGS/Cap Ts-TPGS functionalized calcium phosphate nanorods, TPGS/Cap TPGS-functionalized calcium phosphate nanorods, KPN Klebsiella pneumonia, TRKP tigecycline-resistant Klebsiella pneumonia. Data are shown as the mean ± SD (n = 3 mice for each group). Unpaired two-tailed T-test was performed in C, D. Source data are provided as a Source Data file.